| This week's sponsor is Premier Research. | |  | Rare Cancer Drug Research: What to Know Going In
Rare cancer drug research requires oncology and rare disease expertise and careful attention to trial design and regulatory demands. Get started with our white paper. Premier Research. It's what we do. Best. |
Today's Rundown Featured Story | | | Tuesday, June 19, 2018 Syncona has dialed up its bet on gene therapy startup Freeline Therapeutics. The life science investor committed £85 million ($112 million) to Freeline’s £88 million series B round, thereby maintaining a big stake in a biotech that is working to redefine the treatment of hemophilia B and Fabry disease. |
|
|
| This week's sponsor is Catalent. | |  | |
Top Stories Tuesday, June 19, 2018 Decibel Therapeutics raised $55 million in series C financing and named George Scangos, former Biogen CEO and current CEO of Vir Biotechnology, as chair of its board of directors. Tuesday, June 19, 2018 Israeli microcap Can-Fite BioPharma won’t get a readout from its midstage trial of liver cancer candidate namodenoson as soon as it hoped, but says the data so far are looking good. Monday, June 18, 2018 This informative eBook explores technology currently being used to improve clinical trial efficiency, while also offering a peek into the emerging technologies that will shape the future success of clinical trials. Tuesday, June 19, 2018 Vertex has more than doubled the size of its San Diego research site that discovered key cystic fibrosis drugs. The newly expanded site covers 170,000 square feet, boosting Vertex’s ability to hunt for the next generation of blockbusters. Tuesday, June 19, 2018 Interim phase 2 data show that Leading BioSciences' GI-targeting serine protease inhibitor reduced patients' recovery time and hospital stay. Tuesday, June 19, 2018 Roche is set to spend $2.4 billion to buy the rest of genomic profiling company Foundation Medicine. The deal will further Roche’s precision medicine plans while allowing Foundation to retain autonomy and continue to work with other biopharma companies. Enrollment Showcase | | | Sponsored by: Bioinformatics at UTHealth SBMI UTHealth SBMI now offers a M.S. track in clinical and translational bioinformatics. |
|
|
Resources Life Science Strategy Group Take this anonymous 10-minute survey to share your thoughts on leading eClinical technology solutions and earn up to $55 honoraria. Take the survey now! Sponsored by: Blue Latitude Health Blue Latitude Health explores the commercial barriers and new stakeholder connections for pharma companies developing precision medicines, and reveals how to grasp novel opportunities in the new era of healthcare. Presented By: Covance A solid RBM plan will not only help you comply with the ICH guidelines, but will help you mitigate risks which could ultimately delay your trials and increase costs. Download today! Presented by: Patheon, part of Thermo Fisher Scientific “Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market faster. Quickly proving efficacy in first-in-human (FIH) trials is a make-or-break milestone for these cash-strapped companies whose hopes hinge upon one or two molecules. Read how CDMOs are responding to this pressure. Sponsored by: Seton Hall Law 4-day interactive educational program trusted by multi-national companies as part of their compliance training for employees. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating globally. Visit event homepage for session topics. Sponsored by: Docusign Life science companies are experiencing a significant transformation in how they bring new products to market. | 
